Market Research Logo

Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023

Point of Care Molecular Diagnostics Market by Product & Service (Assays, Kits, Analyzers, Software), Application (Respiratory Disease, Hospital Acquired Infection), Technology (RT-PCR, INAAT), End User (Physician Office, ICUS) - Global Forecast to 2023

“The global POC molecular diagnostics market is projected to grow at a CAGR of 14.7%.”
The global point of care (POC) molecular diagnostics market is expected to reach USD 1440.2 million by 2023 from USD 725.5 million in 2018, at a CAGR of 14.7%. Growth in the POC molecular diagnostics market is driven by the increasing prevalence of infectious diseases, rising focus on decentralized diagnostics, and the growing demand for CLIA-waived molecular POC tests. However, inadequate reimbursement and stringent regulatory policies are likely to restrain the growth of this market during the forecast period.

“The INAAT technology is expected to grow at highest CAGR during the forecast period.”
Based on technology, the POC molecular diagnostics market is segmented into RT-PCR, INAAT, and other technologies. The INAAT segment is expected to grow at highest CAGR during the forecasted period. The increasing popularity of INAAT for infectious diseases diagnosis is expected to drive this market in the coming years.

“Asia Pacific is projected to grow at the highest CAGR during the forecast period.”
While North America is expected to account for the largest share of the global POC molecular diagnostics market, Asia Pacific is projected to grow at the highest CAGR during the study period. The key factors influencing the growth of this market include growing initiatives by market players, rising demand for influenza A/B tests, decentralized healthcare delivery systems, and increasing patient population base in this region.

Break-up profile of primaries:

By Company Type- Tier 40%, Tier 30%, and Tier 30%
By Designation-C-level-27%, D-level-18%, and Others-55%
By Region-North America-50%, Europe-20%, Asia Pacific-20%, and RoW-10%
The key players in the global POC molecular diagnostics market are Roche Diagnostics (Switzerland), Abbott Laboratories (US), Danaher (US), Biomerieux (France), and Meridian Biosciences (US)

Research Coverage:
The POC molecular diagnostics market in this report is segmented by product & service, application, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisition, collaborations, agreements, partnerships, and expansion, and profiles key players and their core competencies in the POC molecular diagnostics market.

Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on portfolios offered by the top players in the global POC molecular diagnostics market. The report analyzes the market by product & service, application type, technology, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global POC molecular diagnostics market
Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for POC molecular diagnostic products across regions
Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global POC molecular diagnostics market
Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global POC molecular diagnostics market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • PRIMARY DATA
      • KEY DATA FROM PRIMARY SOURCES
      • KEY INDUSTRY INSIGHTS
    • SECONDARY DATA
      • KEY DATA FROM SECONDARY SOURCES
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • POC MOLECULAR DIAGNOSTICS MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: APAC POC MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND PRODUCT
    • POC MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
    • POC MOLECULAR DIAGNOSTICS MARKET, BY END USER
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
  • POINT-OF-CARE (POC) MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • RESPIRATORY DISEASES
        • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
      • SEXUALLY TRANSMITTED DISEASES
        • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR SEXUALLY TRANSMITTED DISEASES, BY COUNTRY, 2016–2023 (USD MILLION)
      • HOSPITAL-ACQUIRED INFECTIONS
        • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL-ASSOCIATED INFECTIONS, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITALASSOCIATED INFECTIONS, BY COUNTRY, 2016–2023 (USD MILLION)
      • ONCOLOGY
        • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2016–2023 (USD MILLION)
      • HEPATITIS
        • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR HEPATITIS, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR HEPATITIS, BY COUNTRY, 2016–2023 (USD MILLION)
      • OTHER APPLICATIONS
        • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2023 (USD MILLION)
        • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION)
  • POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
    • RT-PCR
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR RT-PCR, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR RT-PCR, BY COUNTRY, 2016–2023 (USD MILLION)
    • INAAT
      • Table PRODUCT APPROVALS IN THE LAST THREE YEARS
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY COUNTRY, 2016–2023 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION)
  • POINT-OF-CARE (POC) MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
    • ASSAYS & KITS
      • Table POC MOLECULAR DIAGNOSTICS MARKET FOR ASSAYS & KITS, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POC MOLECULAR DIAGNOSTICS MARKET FOR ASSAYS & KITS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
    • INSTRUMENTS/ANALYZERS
      • Table POC MOLECULAR DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POC MOLECULAR DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY, 2016–2023 (USD MILLION)
    • SOFTWARE & SERVICES
      • Table POC MOLECULAR DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POC MOLECULAR DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2016–2023 (USD MILLION)
  • POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
    • PHYSICIAN OFFICES
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR PHYSICIAN OFFICES, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR PHYSICIAN OFFICES, BY COUNTRY, 2016–2023 (USD MILLION)
    • HOSPITAL EMERGENCY DEPARTMENTS & INTENSIVE CARE UNITS
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL EDS & ICUS, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL EDS & ICUS, BY COUNTRY, 2016–2023 (USD MILLION)
    • RESEARCH INSTITUTES
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2016–2023 (USD MILLION)
    • OTHER END USERS
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2016–2023 (USD MILLION)
  • POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • Table NORTH AMERICA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
      • US
        • Table US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
        • Table US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
        • Table US: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
      • CANADA
        • Table CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
        • Table CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
        • Table CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
        • Table CANADA: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
    • EUROPE
      • Table EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION)
      • Table EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • Table EUROPE: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
    • ASIA PACIFIC
      • Table APAC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2018–2023 (USD MILLION)
      • Table APAC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table APAC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • Table APAC: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
    • ROW
      • Table ROW: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2018–2023 (USD MILLION)
      • Table ROW: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION)
      • Table ROW: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION)
      • Table ROW: POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • MARKET OVERVIEW
    • MARKET RANKING ANALYSIS, 2017
      • Table RANK OF COMPANIES IN THE GLOBAL MOLECULAR POC DIAGNOSTIC MARKET, 2017
    • COMPETITIVE SITUATION AND TRENDS
      • PRODUCT LAUNCHES AND APPROVALS
        • Table PRODUCT LAUNCHES, 2015-2018
      • ACQUISITIONS
        • Table ACQUISITIONS, 2015-2018
      • COLLABORATIONS/AGREEMENTS/PARTNERSHIPS
        • Table COLLABORATIONS/PARTNERSHIPS/AGREEMENTS, 2015 & 2018
      • EXPANSIONS
        • Table EXPANSIONS, 2015 TO 2018
  • COMPANY PROFILE
    • ABBOTT LABORATORIES
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED (ALERE)
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED (CEPHEID)
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIOMÉRIEUX SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ROCHE DIAGNOSTICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • QUIDEL
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MERIDIAN BIOSCIENCE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MESA BIOTECH
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GENEPOC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • DXNA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ATLAS GENETICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • SPARTAN BIOSCIENCE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • BIOCARTIS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report